Identification of in vitro (rat liver postmitochondrial S9 fraction) metabolites of the antiprotozoal agent 3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,2-benzisoxazole . 1983

W J Vandenheuvel, and H Skeggs, and B H Arison, and P G Wislocki

Twelve in vitro oxygenated metabolites of 3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,2-benzisoxazole (MK-0436) were produced by incubation of this antiprotozoal agent with the postmitochondrial supernatant (S9) fraction isolated from the livers of rats treated with phenobarbital. Metabolite structure elucidation was achieved using NMR and mass spectrometry. Seven monohydroxy and two dihydroxy metabolites were fully characterized; two other metabolites were partially characterized as dihydroxy derivatives of the drug. The major in vitro metabolite is the 5 axial hydroxy compound, and a minor metabolite is the corresponding ketone. In all cases metabolite formation involved biotransformation on the hexahydrobenzisoxazole ring.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D009593 Nitroimidazoles IMIDAZOLES having a nitro moiety. Nitroimidazole
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000981 Antiprotozoal Agents Substances that are destructive to protozoans. Schizonticides,Agents, Antiprotozoal
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

W J Vandenheuvel, and H Skeggs, and B H Arison, and P G Wislocki
November 1980, Journal of pharmaceutical sciences,
W J Vandenheuvel, and H Skeggs, and B H Arison, and P G Wislocki
December 1984, Journal of pharmaceutical sciences,
W J Vandenheuvel, and H Skeggs, and B H Arison, and P G Wislocki
April 2013, Acta crystallographica. Section E, Structure reports online,
W J Vandenheuvel, and H Skeggs, and B H Arison, and P G Wislocki
April 2009, Acta crystallographica. Section E, Structure reports online,
W J Vandenheuvel, and H Skeggs, and B H Arison, and P G Wislocki
March 2014, Acta crystallographica. Section E, Structure reports online,
W J Vandenheuvel, and H Skeggs, and B H Arison, and P G Wislocki
February 2010, Acta crystallographica. Section E, Structure reports online,
W J Vandenheuvel, and H Skeggs, and B H Arison, and P G Wislocki
December 2008, Acta crystallographica. Section E, Structure reports online,
W J Vandenheuvel, and H Skeggs, and B H Arison, and P G Wislocki
September 2012, Acta crystallographica. Section E, Structure reports online,
W J Vandenheuvel, and H Skeggs, and B H Arison, and P G Wislocki
April 2012, Acta crystallographica. Section E, Structure reports online,
W J Vandenheuvel, and H Skeggs, and B H Arison, and P G Wislocki
June 2013, Acta crystallographica. Section E, Structure reports online,
Copied contents to your clipboard!